Keebeck Wealth Management, LLC Repligen Corp Transaction History

Keebeck Wealth Management, LLC

  • $667 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 02, 2020
SELL
$122.51 - $158.27 $7,350 - $9,496
-60 Closed
0 $0
Q2 2020

Aug 06, 2020
BUY
$94.33 - $140.48 $5,659 - $8,428
60 New
60 $7,000
Q1 2020

May 14, 2020
SELL
$84.96 - $109.14 $849 - $1,091
-10 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$73.84 - $93.08 $738 - $930
10 New
10 $0

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.15B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Keebeck Wealth Management, LLC Portfolio

Follow Keebeck Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email